Latest statistics and disclosures from VV Manager's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Allogene Therapeutics Inc, Homology Medicines Inc, Sutro Biopharma Inc, and represent 100.00% of VV Manager's stock portfolio.
- Reduced shares in these 1 stocks: Allogene Therapeutics Inc (-$48.24M).
- VV Manager was a net seller of stock by $48.24M.
- VV Manager has $184.41M in assets under management (AUM), dropping by -27.62%.